{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:24:43Z","timestamp":1780316683779,"version":"3.54.1"},"reference-count":26,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006484","name":"AbbVie Deutschland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background and Aims<\/jats:title><jats:p>Screening strategies for undiagnosed infections are fundamental for hepatitis C virus (HCV) elimination. We previously investigated HCV prevalence and screening strategies in an urban primary care setting. IV drug abuse, blood transfusion before 1992, immigration, or elevated ALT were identified as risk factors in a post hoc analysis and diagnosed 83% of unknown HCV\u2010RNA\u2010positive cases by screening only 26% of the population.<\/jats:p><jats:p>We aimed to validate prospectively the proposed screening algorithm in two independent urban and rural cohorts and to analyse for potential differences.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Anti\u2010HCV and ALT were included in a routine check\u2010up together with a questionnaire covering risk factors. HCV\u2010RNA was analysed in anti\u2010HCV\u2010positive individuals.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In urban and rural areas, 4323 and 9321 individuals were recruited. The anti\u2010HCV prevalence was 0.56% and 0.49%, and 0.1% of patients were HCV\u2010RNA\u2010positive in both regions. Fifty\u2010two anti\u2010HCV positive patients including eight HCV\u2010RNA\u2010positive cases were unaware of the infection (number needed to screen to detect one unknown anti\u2010HCV\u2010positive individual: 262). At least one of the three aforementioned risk factors or elevated serum ALT was present in 3000 patients (22%). Restricting HCV screening to only those with risk factors, 52% and 75% of all anti\u2010HCV and HCV\u2010RNA\u2010positive undiagnosed patients were identified (number needed to screen: 111).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We confirm prospectively the efficiency of a risk\u2010based HCV screening. The risk\u2010based algorithm should be evaluated in other countries with similarly low HCV prevalence as in Germany to achieve WHO HCV elimination goals.<\/jats:p><\/jats:sec>","DOI":"10.1111\/liv.15516","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T15:10:03Z","timestamp":1673277003000},"page":"785-793","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Confirmation of guideline\u2010defined hepatitis C screening strategies within the \u2018Check\u2010Up35+\u2019 examination in the primary care setting"],"prefix":"10.1111","volume":"43","author":[{"given":"David","family":"Petroff","sequence":"first","affiliation":[{"name":"Clinical Trial Centre University of Leipzig  Leipzig Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingmar","family":"Wolffram","sequence":"additional","affiliation":[{"name":"General Practitioner  Paderborn Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"B\u00e4tz","sequence":"additional","affiliation":[{"name":"LADR Laboratory Group Dr. Kramer &amp; Colleagues  Geesthacht Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Jedrysiak","sequence":"additional","affiliation":[{"name":"LADR Laboratory Group Dr. Kramer &amp; Colleagues  Geesthacht Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Kramer","sequence":"additional","affiliation":[{"name":"LADR Laboratory Group Dr. Kramer &amp; Colleagues  Geesthacht Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Berg","sequence":"additional","affiliation":[{"name":"Division of Hepatology, Department of Medicine II Leipzig University Medical Center  Leipzig Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9233-4064","authenticated-orcid":false,"given":"Johannes","family":"Wiegand","sequence":"additional","affiliation":[{"name":"Division of Hepatology, Department of Medicine II Leipzig University Medical Center  Leipzig Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,1,13]]},"reference":[{"key":"e_1_2_11_2_1","volume-title":"Combating hepatitis B and C to reach elimination by 2030","author":"WHO","year":"2016"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14324"},{"key":"e_1_2_11_4_1","unstructured":"Bundesministerium f\u00fcr Gesundheit Bundesministerium f\u00fcr wirtschaftliche Zusammenarbeit und Entwicklung. Strategie zur Eind\u00e4mmung von HIV Hepatitis B und C und anderen sexuell \u00fcbertragbaren Infektionen.BIS 2030 \u2013 bedarfsorientiert integriert sektor\u00fcbergreifend. Beschluss des Bundeskabinetts vom 6 April 2016.2016;1\u201328."},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12248"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13680"},{"issue":"1","key":"e_1_2_11_7_1","first-page":"27","article-title":"4\u2009years of direct\u2010acting antivirals (DAAs) in the German hepatitis C\u2010registry (DHC\u2010R)","volume":"57","author":"Huppe D","year":"2019","journal-title":"Z Gastroenterol"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.01.011"},{"key":"e_1_2_11_9_1","unstructured":"Screening auf Hepatitis B und C neuer Bestandteil des Gesundheits\u2010Check\u2010Ups.Gemeinsamer Bundesausschuss.2020."},{"key":"e_1_2_11_10_1","unstructured":"Bundesministerium f\u00fcr Gesundheit.Gesundheitsberichterstattung des Bundes. Anspruchsberechtigte an gesetzlichen Gesundheits\u2010Check\u2010Ups und Inanspruchnahme.Federal Ministry of Health;2020."},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1110008"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6902a1"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.08.080"},{"key":"e_1_2_11_14_1","unstructured":"Gemeinsamer Bundesausschuss.Richtlinie des Gemeinsamen Bundesausschusses \u00fcber die Gesundheitsuntersuchungen zur Fr\u00fcherkennung von Krankheiten. Bundesanzeiger 2019 Dec 19;BAnz AT 06.03.2020 B2:1\u201018.Federal Joint Committee."},{"issue":"41","key":"e_1_2_11_15_1","first-page":"679","article-title":"Social status and participation in health checks in men and women in Germany: results from the German Health Update (GEDA), 2009 and 2010","volume":"110","author":"Hoebel J","year":"2013","journal-title":"Dtsch Arztebl Int"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.3390\/v13112327"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13087"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102734"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.102608"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229239"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0252274"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000001052"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10121570"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-056086"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmac025"},{"key":"e_1_2_11_26_1","unstructured":"Statistisches Amt f\u00fcr Hamburg und Schleswig\u2010Holstein.Bev\u00f6lkerung mit Migrationshintergrund in den Hamburger Stadtteilen 2020. 2021 May 31. Report No.: Statistische Berichte Kennziffer A 10 \u2010 j 20 HH.Statistisches Amt f\u00fcr Hamburg und Schleswig\u2010Holstein."},{"key":"e_1_2_11_27_1","unstructured":"Ministerium f\u00fcr Inneres lRIuG.Zuwanderungs\u2010 und Integrationsstatistik Schleswig\u2010Holstein 2017\u20102019.Federal Ministry of the Interior and Community;2022."}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/liv.15516","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/liv.15516","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/liv.15516","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T20:15:21Z","timestamp":1692735321000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/liv.15516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,13]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["10.1111\/liv.15516"],"URL":"https:\/\/doi.org\/10.1111\/liv.15516","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,13]]},"assertion":[{"value":"2022-09-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}